Net Income Summary of Eurofins Scientific SE

Eurofins Scientific SE's latest annual net income in 2023 was 310.2 Million EUR , down -49.16% from previous year.
Eurofins Scientific SE's latest quarterly net income in 2024 Q2 was 97.05 Million EUR , down 0.0% from previous quarter.
Eurofins Scientific SE reported an annual net income of 610.2 Million EUR in 2022, down -22.03% from previous year.
Eurofins Scientific SE reported an annual net income of 782.6 Million EUR in 2021, up 45.09% from previous year.
Eurofins Scientific SE reported a quarterly net income of 97.05 Million EUR for 2024 Q1, down -38.89% from previous quarter.
Eurofins Scientific SE reported a quarterly net income of 62.35 Million EUR for 2023 Q1, down -79.25% from previous quarter.

Annual Net Income Chart of Eurofins Scientific SE (2023 - 2002)

Historical Annual Net Income of Eurofins Scientific SE (2023 - 2002)

Year	Net Income	Net Income Growth
2023	310.2 Million EUR	-49.16%
2022	610.2 Million EUR	-22.03%
2021	782.6 Million EUR	45.09%
2020	539.4 Million EUR	176.33%
2019	195.2 Million EUR	-12.82%
2018	223.9 Million EUR	3.29%
2017	216.77 Million EUR	24.58%
2016	173.99 Million EUR	99.27%
2015	87.31 Million EUR	10.38%
2014	79.1 Million EUR	9.59%
2013	72.18 Million EUR	9.49%
2012	65.92 Million EUR	18.98%
2011	55.4 Million EUR	136.78%
2010	23.4 Million EUR	307.35%
2009	-11.28 Million EUR	-163.72%
2008	17.71 Million EUR	0.41%
2007	17.63 Million EUR	0.74%
2006	17.5 Million EUR	41.27%
2005	12.39 Million EUR	57.95%
2004	7.84 Million EUR	386.12%
2003	1.61 Million EUR	1061.15%
2002	139 Thousand EUR	0.0%

Year	Net Income	Net Income Growth
2024 Q2	97.05 Million EUR	0.0%
2024 Q1	97.05 Million EUR	-38.89%
2023 Q1	62.35 Million EUR	-79.25%
2023 Q3	65.9 Million EUR	-56.5%
2023 Q2	151.5 Million EUR	142.98%
2023 Q4	158.8 Million EUR	140.97%
2023 FY	310.2 Million EUR	-49.16%
2022 Q3	144.6 Million EUR	-53.31%
2022 Q4	300.5 Million EUR	107.81%
2022 FY	610.2 Million EUR	-22.03%
2022 Q1	145.85 Million EUR	-60.27%
2022 Q2	309.7 Million EUR	112.34%
2021 Q4	367.1 Million EUR	109.11%
2021 Q2	415.5 Million EUR	109.11%
2021 Q1	198.7 Million EUR	-55.33%
2021 FY	782.6 Million EUR	45.09%
2021 Q3	175.55 Million EUR	-57.75%
2020 FY	539.4 Million EUR	176.33%
2020 Q1	39.35 Million EUR	-71.14%
2020 Q3	213.3 Million EUR	125.24%
2020 Q2	94.7 Million EUR	140.66%
2020 Q4	444.8 Million EUR	108.53%
2019 FY	195.2 Million EUR	-12.82%
2019 Q1	17.35 Million EUR	-67.99%
2019 Q2	58.87 Million EUR	239.33%
2019 Q3	55.4 Million EUR	-5.9%
2019 Q4	136.32 Million EUR	146.08%
2018 Q1	33.45 Million EUR	-45.48%
2018 FY	223.9 Million EUR	3.29%
2018 Q2	33.45 Million EUR	0.0%
2018 Q3	54.19 Million EUR	62.03%
2018 Q4	54.19 Million EUR	0.0%
2017 Q3	61.35 Million EUR	116.26%
2017 FY	216.77 Million EUR	24.58%
2017 Q4	61.35 Million EUR	0.0%
2017 Q1	28.36 Million EUR	-40.37%
2017 Q2	28.36 Million EUR	0.0%
2016 Q2	21.61 Million EUR	0.0%
2016 Q1	21.61 Million EUR	65.68%
2016 Q3	47.57 Million EUR	120.16%
2016 Q4	47.57 Million EUR	0.0%
2016 FY	173.99 Million EUR	99.27%
2015 Q1	15.13 Million EUR	-45.34%
2015 Q4	13.04 Million EUR	0.0%
2015 Q3	13.04 Million EUR	-13.83%
2015 FY	87.31 Million EUR	10.38%
2015 Q2	15.13 Million EUR	0.0%
2014 FY	79.1 Million EUR	9.59%
2014 Q3	27.69 Million EUR	145.25%
2014 Q1	11.29 Million EUR	-26.22%
2014 Q2	11.29 Million EUR	0.0%
2014 Q4	27.69 Million EUR	0.0%
2013 Q1	11.26 Million EUR	-51.9%
2013 FY	72.18 Million EUR	9.49%
2013 Q4	15.3 Million EUR	0.0%
2013 Q3	15.3 Million EUR	35.91%
2013 Q2	11.26 Million EUR	0.0%
2012 Q2	- EUR	-100.0%
2012 Q4	23.41 Million EUR	0.0%
2012 Q3	23.41 Million EUR	0.0%
2012 FY	65.92 Million EUR	18.98%
2012 Q1	15.97 Million EUR	-31.89%
2011 Q3	18.13 Million EUR	43.27%
2011 Q2	12.65 Million EUR	658.02%
2011 Q1	1.67 Million EUR	-86.36%
2011 FY	55.4 Million EUR	136.78%
2011 Q4	23.45 Million EUR	29.32%
2010 FY	23.4 Million EUR	307.35%
2010 Q2	6.3 Million EUR	347.35%
2010 Q1	-2.54 Million EUR	85.18%
2010 Q3	15.84 Million EUR	151.43%
2010 Q4	12.24 Million EUR	-22.7%
2009 Q3	3.01 Million EUR	1951.02%
2009 Q1	-3.02 Million EUR	-167.16%
2009 Q4	-17.18 Million EUR	-669.88%
2009 Q2	147 Thousand EUR	104.85%
2009 FY	-11.28 Million EUR	-163.72%
2008 Q4	4.51 Million EUR	0.0%
2008 FY	17.71 Million EUR	0.41%
2008 Q2	4.51 Million EUR	0.0%
2008 Q1	4.51 Million EUR	-8.29%
2008 Q3	4.51 Million EUR	0.0%
2007 Q2	4.91 Million EUR	0.0%
2007 Q1	4.91 Million EUR	1.78%
2007 FY	17.63 Million EUR	0.74%
2007 Q4	4.91 Million EUR	0.0%
2007 Q3	4.91 Million EUR	0.0%
2006 Q4	4.83 Million EUR	0.0%
2006 FY	17.5 Million EUR	41.27%
2006 Q2	4.83 Million EUR	0.0%
2006 Q1	4.83 Million EUR	39.86%
2006 Q3	4.83 Million EUR	0.0%
2005 Q2	3.45 Million EUR	0.0%
2005 FY	12.39 Million EUR	57.95%
2005 Q1	3.45 Million EUR	76.92%
2005 Q4	3.45 Million EUR	0.0%
2005 Q3	3.45 Million EUR	0.0%
2004 Q1	1.95 Million EUR	359.47%
2004 Q4	1.95 Million EUR	0.0%
2004 Q2	1.95 Million EUR	0.0%
2004 Q3	1.95 Million EUR	0.0%
2004 FY	7.84 Million EUR	386.12%
2003 Q2	425 Thousand EUR	0.0%
2003 Q4	425 Thousand EUR	0.0%
2003 FY	1.61 Million EUR	1061.15%
2003 Q1	425 Thousand EUR	813.98%
2003 Q3	425 Thousand EUR	0.0%
2002 FY	139 Thousand EUR	0.0%
2002 Q2	46.5 Thousand EUR	0.0%
2002 Q3	46.5 Thousand EUR	0.0%
2002 Q4	46.5 Thousand EUR	0.0%
2002 Q1	46.5 Thousand EUR	0.0%

Peer Net Income Comparison of Eurofins Scientific SE

Name	Net Income	Net Income Difference
Biosynex SA	-36.94 Million EUR	939.604%
Predilife S.A.	-4.22 Million EUR	7443.562%
bioMérieux S.A.	357.6 Million EUR	13.255%
Lumibird SA	7.12 Million EUR	-4253.073%

Global Stocks Search

Eurofins Scientific SE (ERF.PA)

Net Income Summary of Eurofins Scientific SE

Annual Net Income Chart of Eurofins Scientific SE (2023 - 2002)

Historical Annual Net Income of Eurofins Scientific SE (2023 - 2002)

Peer Net Income Comparison of Eurofins Scientific SE